The Trump administration is reportedly considering linking the use of acetaminophen, commonly known as Tylenol, during pregnancy to an increased risk of autism in children. The administration is expected to recommend that the drug be used only for high fevers, not for mild discomforts.
According to reports, the administration is reviewing findings from a study suggesting that acetaminophen use during pregnancy may be associated with an increased risk of autism spectrum disorder in offspring. However, the study is not yet peer-reviewed, and experts warn that more research is needed before making such recommendations. Health officials have emphasized that the potential link is still under investigation, and no definitive conclusion has been reached.
The proposed guidelines would mark a significant shift in the administration’s approach to drug safety, as previous recommendations have not included such restrictions. Critics argue that the decision could have negative consequences for pregnant women who rely on acetaminophen for pain relief. The administration has not provided a specific timeline for implementing the new guidelines, but sources indicate that the policy is expected to be finalized by the end of the year.
Health advocates have called for caution in the administration’s approach, emphasizing the need for more rigorous scientific evidence before making such recommendations. They argue that the potential benefits of acetaminophen in managing pain and fever during pregnancy should not be overlooked. The administration’s stance has sparked debate among medical professionals and public health experts, with some supporting the move to protect fetal development and others warning against premature regulatory action.